Charles Matouk is a Neurology physician affiliated with Yale Cancer Center. OpenAlex indexes 501 publications with 10,700 citations (h-index 47); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Neurological Surgery profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- MMA Embolization With NeoCast for Subacute and Chronic Subdural Hematoma
Sponsor: Arsenal Medical, Inc.
Overall officialNot, yet, recruitingNCT07541404 - REVascularization In Large VEssel Occlusion for Acute Ischemic Stroke
Sponsor: Microvention-Terumo, Inc.
Overall officialNot, yet, recruitingNCT07216170 - Feasibility Study of the Treatment of Acute Ischemic Stroke Using the NOVIS Transcarotid Neuroprotection System
Sponsor: Silk Road Medical
Overall officialTerminatedNCT04881162
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
8 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
NIH funding
2 NIH research awards on record, funded 2020–2024 per NIH RePORTER. The latest:
- Electroencephalographic signatures of dysfunctional cerebrovascular autoregulation as biomarkers of brain injury in aneurysmal subarachnoid hemorrhage (SAH)
Yale University
FY2024$209,375R21NS128641 - Electroencephalographic signatures of dysfunctional cerebrovascular autoregulation as biomarkers of brain injury in aneurysmal subarachnoid hemorrhage (SAH)
Yale University
FY2023$251,250R21NS128641 - Single cell transcriptomics to determine stroke etiology and outcomes after thrombectomy
Yale University
FY2020$460,625R21NS119992
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Ian Krop, MD
Yale Cancer Center
Maryam Lustberg, MD
Yale Cancer Center
Pamela Kunz, MD
Yale Cancer Center
Anne Chiang, MD
Yale Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”